BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
FXYD4
,
cell-cell adhesion
,
Breast Cancer
,
Retina
,
Anticancer prodrugs
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
tak 778
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
TAK-778 induces osteogenesis in ovariectomized rats via an estrogen receptor-dependent pathway.
The effect of TAK-778 on gene expression of osteoblastic cells is mediated through estrogen receptor…
Participation of estrogen receptors in the enhancement of osteoblast differentiation by TAK-778.
Effect of beta-TCP containing the bone-growth promoting compound, TAK-778, on the vertex bone of rat…
Ex vivo comparison of microbicide efficacies for preventing HIV-1 genomic integration in intraepithe…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants
A Study of TAK-341 in Treatment of Multiple System Atrophy
Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia
Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants …
Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepat…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ